JAMDA
September 27, 2022
Showing 1951 - 1960 of 7362 results
JAMDA
June 15, 2023
Changes in Personality Before and During Cognitive Impairment
Clinical observations and studies of retrospective observer ratings point to changes in personality in persons with cognitive impairment or dementia. The timing and magnitude of such changes, however, are unclear. This study used prospective self-reported data to examine the trajectories of personality tra...
JAMDA
June 13, 2024
Care Providers’ Perspectives on the Design of Assistive Persuasive Behaviors for Socially Assistive Robots
The main objectives of this research are (1) to uniquely design assistive behaviors for socially assistive robots using the principles of persuasion from behavioral psychology, and (2) to investigate caregivers’ perspectives and opinions on the use of these behaviors to engage and motivate older adults in ...
JAMDA
August 5, 2023
Use of Diabetes Medications before and after a Heart Failure–Related Hospitalization among Nursing Home Residents
Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer cardiovascular benefits, whereas thiazolidinediones (TZDs) and sulfonylureas (SUs) increase cardiovascular risk. The objective of this study was to describe the use of SGLT-2is, GLP-1RAs, TZD...
JAMDA
November 26, 2024
A Team Coaching Intervention for Dementia Care: Acceptability and Feasibility Study in Care Communities
In 2018, the Alzheimer's Association published the Dementia Care Practice Recommendations (DCPR) to provide guidance on quality care for professionals. This study aimed to examine the feasibility and acceptability of a consultative coaching program to increase adoption of the DCPR.
JAMDA
August 5, 2020
Muscle Density, but Not Size, Correlates Well With Muscle Strength and Physical Performance
There is increasing evidence that muscle volume and mass are poor predictors of muscle strength and physical performance. Other assessments of muscle quality such as skeletal muscle density measured by computed tomography (CT) may be more important. The aim of this study was to explore associations of musc...
JAMDA
January 8, 2021
Longitudinal Changes in Muscle Mass, Muscle Strength, and Physical Performance in Acutely Hospitalized Older Adults
Acute hospitalization may lead to a decrease in muscle measures, but limited studies are reporting on the changes after discharge. The aim of this study was to determine longitudinal changes in muscle mass, muscle strength, and physical performance in acutely hospitalized older adults from admission up to ...
JAMDA
March 3, 2021
Emergency Department Interventions for Frailty (EDIFY): Front-Door Geriatric Care Can Reduce Acute Admissions
The EDIFY program was developed to deliver early geriatric specialist interventions at the emergency department (ED) to reduce the number of acute admissions by identifying patients for safe discharge or transfer to low-acuity care settings. We evaluated the effectiveness of EDIFY in reducing potentially a...
JAMDA
February 5, 2014
Development and Testing of a Decision Aid on Goals of Care for Advanced Dementia
Decision aids are effective to improve decision-making, yet they are rarely tested in nursing homes (NHs). Study objectives were to (1) examine the feasibility of a goals of care (GOC) decision aid for surrogate decision-makers (SDMs) of persons with dementia; and (2) to test its effect on quality of commu...
Sponsored Education
Apr 30, 2026 12:00 pm - Apr 30, 2026 1:00 pm
First-Line Prescription Treatment for Hallucinations and Delusions Associated with Parkinson's Disease Psychosis in the LTC Setting
Hallucinations and delusions are common, underreported nonmotor symptoms of Parkinson's disease (PD) that can significantly impact patients and caregivers. Attempting to manage hallucinations and delusions in patients with PD can present a therapeutic bind. Join Malcolm Fraser, MD, CMD, for a presentation exploring these challenges as well as a review of the clinical efficacy and safety of a treatment option. Additionally, real-world evidence from 2 retrospective analyses investigating the risk of all-cause mortality among patients with PD psychosis treated with atypical antipsychotics will be presented.